Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

4
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
4

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosis.

Acta neurologica Belgica·2026
Same author

Dynamic compression of whole-brain neural trajectories during human motor learning.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Coronary Artery Disease Is Linked with Demyelination and Iron Deposition in White Matter Watershed Areas.

Aging and disease·2026
Same author

Morpho-phenological and pomological characteristics in differentiating and selecting superior quince (Cydonia oblonga mill.).

BMC plant biology·2026
Same author

Manifold Interactions between the Action-Mode Network and Sensorimotor Cortex during Human Motor Learning.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Letter to the editor: "Association of the G8 score with urinary continence recovery after robot-assisted radical prostatectomy".

World journal of urology·2026
Same journal

Synergistic pain relief in cervical radiculopathy: A randomized trial of topical methylcobalamin gel with phonophoresis and Mulligan mobilization.

Acta neurologica Belgica·2026
Same journal

Characterizing cranial tremors in a case of spinocerebellar ataxia type 12: a unique positional tremor.

Acta neurologica Belgica·2026
Same journal

A case of coexistence of spinal intradural capillary hemangioma and craniocervical junction dural arteriovenous fistula.

Acta neurologica Belgica·2026
Same journal

Comment on "Content quality and reliability of youtube exercise videos for parkinson's disease".

Acta neurologica Belgica·2026
Same journal

A novel CHMP2B variant of uncertain significance in a patient with apathy, hyperorality, and mild language impairment.

Acta neurologica Belgica·2026
Same journal

Photon-counting CT-angiography in comparison to digital subtraction angiography and MR-angiography for assessing intra-aneurysmal flow disrupting devices.

Acta neurologica Belgica·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.8K

Multiple sclerosis and hyperprolactinemia: a case-control study.

Masoud Etemadifar1, Mohammad Amin Najafi, Mohammad Reza Najafi

  • 1Department of Neurology, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Acta Neurologica Belgica
|December 16, 2014
PubMed
Summary
This summary is machine-generated.

Hyperprolactinemia in multiple sclerosis (MS) patients was linked to a higher relapse rate but showed a protective effect against demyelination. Further research is needed to understand prolactin's role in MS progression.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.2K

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.8K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.2K

Area of Science:

  • Neuroimmunology
  • Endocrinology

Background:

  • Multiple sclerosis (MS) is a central nervous system autoimmune disease characterized by demyelination.
  • Prolactin, produced by the anterior pituitary, influences immune cell maturation, suggesting a potential role in autoimmune processes like MS.
  • Hyperprolactinemia, elevated prolactin levels, has been investigated for its impact on MS pathogenesis.

Purpose of the Study:

  • To investigate the role of hyperprolactinemia in the context of multiple sclerosis.
  • To compare relapse rates and disease severity between MS patients with and without hyperprolactinemia.

Main Methods:

  • A case-control study involving 22 MS patients with hyperprolactinemia (due to pituitary adenoma) and 66 MS patients without hyperprolactinemia.
  • Patients were matched for age, gender, and MS subtypes. Exclusion criteria included other autoimmune diseases and pregnancy.
  • Statistical analyses utilized the Pearson Chi-square test and t test, with significance set at p < 0.05.

Main Results:

  • MS patients with hyperprolactinemia exhibited a significantly higher relapse rate (p < 0.001).
  • A statistically significant difference in Expanded Disability Status Scale (EDSS) scores was observed between the groups (1.3 vs. 1.9; p = 0.007).
  • A significant positive correlation was found between MS duration and hyperprolactinemia duration in the hyperprolactinemic group (p < 0.05, R = 0.752).

Conclusions:

  • The study suggests a potential protective role for prolactin in the demyelination process within multiple sclerosis.
  • Hyperprolactinemia in MS is associated with increased relapse rates and potentially higher disease severity.
  • Further investigation is warranted to elucidate the complex relationship between prolactin and MS pathology.